Tramview Capital Management’s Post

💰 3Daughters, a clinical development company dedicated to advancing women’s healthcare, has closed an oversubscribed seed financing round, raising $4.7 million. This round saw participation from existing investors including Thairm Bio, Argosy Foundation Wexford Science & Technology, LLC, University of Massachusetts Amherst, and new undisclosed investors. 💬 "We are thrilled by the overwhelming response from both our existing and new investors who share our determination and dedication to improving therapies for women, starting with our advanced IUD and integrated system for insertion and retrieval. Notably, this oversubscribed round supports our preclinical development through an IND filing in early 2025, a major milestone in our development timeline." Mary Beth Cicero, 3Daughters CEO #femtech #womenshealth #reproductivehealth #iud #birthcontrol #contraception #health #healthcare #medtech #medicaldevice #investment #startup #healthtech #vc #venturecapital

I'm thrilled to announce that my latest article, "A Case Series Based on the Mixed Double-Embryo Transfer (MDET) Outcome in Patients With Recurrent Implantation Failure," has been successfully published! 🎉 This research delves into Mixed Double-Embryo Transfer (MDET) outcomes in patients facing recurrent implantation failure. It's a culmination of hard work, dedication, and the collaborative efforts of a fantastic team. Thanks to my juniors, Sanket Mahajan and Neha Nawale, for their keen interest and assistance in the write-up of the article. I invite you to read the article and share your thoughts! Your feedback is invaluable to me. If you find the study intriguing or have any insights, please comment and share your perspective. Your engagement helps foster a richer understanding of this critical subject. If you enjoyed the content and found it insightful, don't hesitate to rate the article! Your support means the world to me and contributes to disseminating necessary research in our field. Let's continue advancing knowledge together! 🌐💡 #ResearchPublication #CaseSeries #MDET #RecurrentImplantationFailure #MedicalResearch #ScienceCommunity #LinkedInPost #HealthcareInnovation

One of the services offered by Embryo Care's Senior Embryologists includes 𝙋𝙖𝙩𝙞𝙚𝙣𝙩 𝙉𝙤𝙩𝙞𝙛𝙞𝙘𝙖𝙩𝙞𝙤𝙣 𝙎𝙚𝙧𝙫𝙞𝙘𝙚𝙨, designed to ensure clear communication throughout the fertility journey. This service ensures prompt updates on laboratory outcomes, keeping patients informed while freeing up embryologists to focus on their essential lab work instead of spending time on the phone delivering results. 𝐊̲𝐞̲𝒚 ̲𝐅̲𝐞̲𝐚̲𝐭̲𝐮̲𝐫̲𝐞̲𝐬̲: 𝐓𝐢𝐦𝐞𝐥𝐲 𝐍𝐨𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬: Quick delivery of laboratory results to avoid patient anxiety. 𝐂𝐥𝐞𝐚𝐫 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧: Complex information is made understandable, keeping patients well-informed at every step. Understanding the importance of clear and timely communication, Embryo Care aims not just to deliver results, but to offer peace of mind and support, preparing patients for the next steps in their treatment. Clinic managers committed to improving patient care through better communication are encouraged to connect with us through our website: https://www.embryocare.art

🍼The clinical-stage medical device company developing medical technologies to improve outcomes for mothers and babies during childbirth, announced it has oversubscribed Series A3 extension round, which it will use to support two clinical studies of the Lumerah™ and Daisy™ technologies. 👏 “We are honored to partner with funds that recognize the life-saving potential of our groundbreaking devices and share our mission, vision and values,” says Raydiant Oximetry, Inc. founder and CEO Neil Ray. 👉 Read more: https://lnkd.in/dFKpaQdE 📰 Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/dufuVJsc #MedicalDevices #MedicalDevice #MedicalEquipment #Medicine #HealthTech #Surgeons #GuidedSolutions

Check this out! Dr. McKnight provides such valuable insight in this piece.

Women in Healthcare: Clinical studies and expertise Our very first clinical trial in 1999 was in postmenopausal women - 25 years later, gynecology is still one of our core competencies and our female colleagues are still at the forefront of our business. 💡 The 1999 study was designed to demonstrate the bioavailability and pharmacodynamics of a grandfather drug. A drug that had been used in females for decades but was still poorly understood. 🤝 From 2011 onwards, dinox GmbH has been our strong partner for clinical trials in gynecology. 👩💼 Experience meets expertise: Also on the other side of the clinical trials, our women are strong in coordinating, monitoring, reporting, submitting and everything else it takes to run successful studies.  🎉Happy Women's Day!

𝐈𝐌𝐏𝐎𝐑𝐓𝐀𝐍𝐓 𝐔𝐏𝐃𝐀𝐓𝐄: 𝐒𝐌𝐅𝐌 𝐫𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐬 𝐓𝐀𝐏𝐒 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐟𝐫𝐨𝐦 𝟏𝟔 𝐰𝐞𝐞𝐤𝐬! We're 𝐞𝐜𝐬𝐭𝐚𝐭𝐢𝐜 to see The Society for Maternal-Fetal Medicine release an update to their screening guidelines for monochorionic twins in Consult Series #72. These new guidelines not only 𝐞𝐦𝐩𝐡𝐚𝐬𝐢𝐳𝐞 𝐭𝐡𝐞 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐞𝐚𝐫𝐥𝐲 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐓𝐀𝐏𝐒 by recommending bi-weekly screenings from 16 weeks but also acknowledge the severe long-term outcomes of twin anemia-polycythemia sequence (TAPS). With the recommendation to refer to a tertiary center at stage 2 and the use of delta MCA-PSV for diagnosis, 𝐭𝐡𝐢𝐬 𝐢𝐬 𝐚 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐬𝐭𝐞𝐩 𝐟𝐨𝐫𝐰𝐚𝐫𝐝 𝐢𝐧 𝐜𝐚𝐫𝐞 𝐟𝐨𝐫 𝐨𝐮𝐫 𝐔𝐒 𝐛𝐚𝐬𝐞𝐝 𝐟𝐚𝐦𝐢𝐥𝐢𝐞𝐬. At TAPS Support, we're passionate about spreading the word on 𝐭𝐡𝐞 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐓𝐀𝐏𝐒 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 for families of monochorionic twins. 𝐖𝐞'𝐫𝐞 𝐡𝐞𝐫𝐞 𝐭𝐨 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐛𝐨𝐭𝐡 𝐟𝐚𝐦𝐢𝐥𝐢𝐞𝐬 𝐚𝐟𝐟𝐞𝐜𝐭𝐞𝐝 𝐛𝐲 𝐓𝐀𝐏𝐒 𝐚𝐧𝐝 𝐜𝐚𝐫𝐞 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐫𝐬, helping them understand and navigate these critical developments. This is a crucial change, and 𝐰𝐞'𝐫𝐞 𝐜𝐨𝐦𝐦𝐢𝐭𝐭𝐞𝐝 𝐭𝐨 𝐞𝐧𝐬𝐮𝐫𝐢𝐧𝐠 𝐞𝐯𝐞𝐫𝐲𝐨𝐧𝐞 𝐡𝐚𝐬 𝐭𝐡𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐭𝐡𝐞𝐲 𝐧𝐞𝐞𝐝. 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐮𝐩𝐝𝐚𝐭𝐞𝐝 𝐠𝐮𝐢𝐝𝐞𝐥𝐢𝐧𝐞𝐬 𝐟𝐨𝐫 𝐓𝐀𝐏𝐒 𝐚𝐧𝐝 𝐓𝐓𝐓𝐒 𝐡𝐞𝐫𝐞: https://bit.ly/4cOBtpV. 𝐇𝐞𝐥𝐩 𝐮𝐬 𝐬𝐩𝐫𝐞𝐚𝐝 𝐭𝐡𝐞 𝐰𝐨𝐫𝐝 on this important update by the SMFM by sharing, liking, and engaging with this post, and congratulating them on this important change to their recommendations! #TAPSSupport #TAPSIsReal #SMFM #TAPSScreening

🥚 🥚 Signati Medical Inc. has enrolled the first patient in a clinical IDE trial investigating its Separo device designed to quicken vasectomy procedures. The company states the device can significantly reduce procedure time and offer a minimally invasive approach. Separo can seal each vas deferens in four seconds, according to the US company. Signati’s CEO William Prentice said: “While highly effective, the traditional vasectomy procedure can be time-consuming and create anxiety for patients. The Signati Separo can potentially transform vasectomies into a faster, more streamlined experience.” 🗞 Learn more: https://lnkd.in/dtXPj3h2 📰 Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/dntmVKBc #MedicalDevices #MedicalDevice #MedicalEquipment #Medicine #Surgeons #ReproductiveHealth #GuidedSolutions

The fetal monitoring market has seen substantial growth, projected to reach $3.91 billion in 2024 with a CAGR of 7.5%. This growth is driven by the increasing incidence of preterm births, prompting the need for fetal monitoring devices. Technological advancements, such as AI-based platforms like PeriGen Inc.’s LaborWatch, are enhancing patient safety. Strategic acquisitions, like GE Healthcare Technologies Inc.’s acquisition of BK Medical Holding Company Inc., further expand solutions. Major players are like FUJIFILM Holdings America Corporation, Medtronic, Siemens Healthineers AG. Read more https://lnkd.in/gh7yHk8C #fetalmonitoring #healthcare #innovation #tbrc #thebusinessresearchcompany #marketresearch #marketintelligence

Outsourcing Neurology Billing Services to Unify Healthcare Services is a step in the right direction. Get ready to improve the cash flow in your healthcare organization. The professionals are ready to tackle every challenge that comes in the way of a smooth revenue cycle. It is time to stay ahead in the competition and reduce the chances of claim denials. 🌐 www.unifyrcm.com 📧 info@unifyrcm.com 📞 +1 (866)796-0858 #UnifyHealthcareServices #UnifyRCM #RCM #PhysicianBilling #DME #HME #medicalbillingservices #healthcarebilling #medicalcoding #medicalbilling #Outsourcing #NeurologyBilling #RevenueCycleManagement #ClaimDenials #CompetitiveAdvantage #ProfessionalServices #HealthcareRevenue #BillingSolutions #RevenueOptimization #NeurostimulatorProcedures #PulseGenerator #EEG